Cargando…
RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes
Diabetes exacerbates cardiovascular disease, at least in part through suppression of macrophage cholesterol efflux and levels of the cholesterol transporters ATP binding cassette transporter A1 (ABCA1) and ABCG1. The receptor for advanced glycation end products (RAGE) is highly expressed in human an...
Autores principales: | Daffu, Gurdip, Shen, Xiaoping, Senatus, Laura, Thiagarajan, Devi, Abedini, Andisheh, Hurtado del Pozo, Carmen, Rosario, Rosa, Song, Fei, Friedman, Richard A., Ramasamy, Ravichandran, Schmidt, Ann Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657581/ https://www.ncbi.nlm.nih.gov/pubmed/26253613 http://dx.doi.org/10.2337/db15-0575 |
Ejemplares similares
-
RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin
por: Machado-Lima, Adriana, et al.
Publicado: (2020) -
Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond
por: Daffu, Gurdip, et al.
Publicado: (2013) -
Molecular basis of cholesterol efflux via ABCG subfamily transporters
por: Sun, Yingyuan, et al.
Publicado: (2021) -
Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice
por: Juranek, Judyta K., et al.
Publicado: (2016) -
Mangiferin promotes macrophage cholesterol efflux and protects against atherosclerosis by augmenting the expression of ABCA1 and ABCG1
por: Ren, Kun, et al.
Publicado: (2019)